Doctors stop offering AstraZeneca jabs over legal risk

11 April 2021 - Many of the nation’s GPs are refusing to offer AstraZeneca’s vaccine to people under 50 until ...

Read more →

ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns

8 April 2021 - A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on the AstraZeneca COVID-19 vaccine in ...

Read more →

‘Before end of this year’: Novavax COVID vaccine could be months away

8 April 2021 - Regulatory approvals for the third pillar of Australia’s vaccine strategy may not be obtained until the ...

Read more →

Wider storage and transportation conditions for the Pfizer COVID-19 vaccine now approved

8 April 2021 - The Therapeutic Goods Administration has recently approved wider storage and transportation conditions for the Pfizer COVID-19 ...

Read more →

Statement by Acting Australian Government Chief Medical Officer, Professor Michael Kidd and Head of the Therapeutic Goods Administration Adjunct Professor John Skerritt

2 April 2021 - Australia's vaccine safety and regulatory process is world class and people can be confident that vaccines ...

Read more →

Melbourne made COVID-19 vaccine now available

23 March 2021 - The Melbourne manufactured AstraZeneca vaccine is now available for Australians, with the TGA this evening approving ...

Read more →

ATAGI statement and clinical guidance on AstraZeneca COVID-19 vaccine following EMA safety review

19 March 2021 - This statement from the Australian Technical Advisory Group on Immunisation updates advice previous provided on 16 March.  ...

Read more →

TGA approves CSL - Seqirus to manufacture AstraZeneca COVID-19 vaccine in Australia

21 March 2021 - Earlier today, the Therapeutic Goods Administration approved manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia.  ...

Read more →

AstraZeneca vaccine allowed by government regulators to be produced in Australia

21 March 2021 - Astra Zeneca vaccines will be produced in Australia from now on after the regulators approved doses being ...

Read more →

AstraZeneca ChAdOx1-S COVID-19

18 March 2021 - The TGA is closely reviewing reports of anaphylaxis after four cases were reported following the AstraZeneca ChAdOx1-S ...

Read more →

ATAGI statement in response to European decisions about the AstraZeneca vaccine

16 March 2021 - ATAGI notes the suspension of the AstraZeneca vaccine program in several European countries due to reports ...

Read more →

Doctors complain of ‘gag’ over AstraZeneca vaccine

16 March 2021 - High-profile doctors have complained they are being gagged from speaking out about their concerns on the ...

Read more →

Approval of updated storage conditions for the Pfizer COVID-19 vaccine

13 March 2021 - The TGA has received and assessed additional data submitted by Pfizer for their COVID-19 vaccine (COMIRNATY - ...

Read more →

COVID-19 vaccines - safety and effectiveness in older adults

10 March 2021 - Data on real-world use of COVID-19 vaccines approved in Australia provides reassurance about their safety in ...

Read more →

TGA adopts Access Consortium guidance for fast-tracking authorisations of modified COVID-19 vaccines for variant

5 March 2021 - TGA has adopted guidance developed by the Access Consortium - a coalition of regulatory authorities from ...

Read more →